The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Morphine Sulfate Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Morphine Sulfate Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1751397

No of Pages : 95

Synopsis
The global Morphine Sulfate Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Morphine Sulfate Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Drug Concentration and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Morphine Sulfate Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Morphine Sulfate Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Morphine Sulfate Injection market size and forecasts, by Drug Concentration and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Morphine Sulfate Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Morphine Sulfate Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Morphine Sulfate Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hameln Pharma, Pfizer Inc., Piramal Pharma, Fresenius Kabi and Sterinova, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Morphine Sulfate Injection market is split by Drug Concentration and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Drug Concentration, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Drug Concentration
Below 5 mg/ml
5-10 mg/ml
Above 10 mg/ml
Market segment by Application
Hospital
Clinic
Others
Major players covered
Hameln Pharma
Pfizer Inc.
Piramal Pharma
Fresenius Kabi
Sterinova
Nephron Pharmaceuticals
Qinghai Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Morphine Sulfate Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Morphine Sulfate Injection, with price, sales, revenue and global market share of Morphine Sulfate Injection from 2018 to 2023.
Chapter 3, the Morphine Sulfate Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Morphine Sulfate Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Drug Concentration and application, with sales market share and growth rate by drug concentration, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Morphine Sulfate Injection market forecast, by regions, drug concentration and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Morphine Sulfate Injection.
Chapter 14 and 15, to describe Morphine Sulfate Injection sales channel, distributors, customers, research findings and conclusion.
Index
1 Market Overview
1.1 Product Overview and Scope of Morphine Sulfate Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Drug Concentration
1.3.1 Overview: Global Morphine Sulfate Injection Consumption Value by Drug Concentration: 2018 Versus 2022 Versus 2029
1.3.2 Below 5 mg/ml
1.3.3 5-10 mg/ml
1.3.4 Above 10 mg/ml
1.4 Market Analysis by Application
1.4.1 Overview: Global Morphine Sulfate Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Morphine Sulfate Injection Market Size & Forecast
1.5.1 Global Morphine Sulfate Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Morphine Sulfate Injection Sales Quantity (2018-2029)
1.5.3 Global Morphine Sulfate Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Hameln Pharma
2.1.1 Hameln Pharma Details
2.1.2 Hameln Pharma Major Business
2.1.3 Hameln Pharma Morphine Sulfate Injection Product and Services
2.1.4 Hameln Pharma Morphine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Hameln Pharma Recent Developments/Updates
2.2 Pfizer Inc.
2.2.1 Pfizer Inc. Details
2.2.2 Pfizer Inc. Major Business
2.2.3 Pfizer Inc. Morphine Sulfate Injection Product and Services
2.2.4 Pfizer Inc. Morphine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Inc. Recent Developments/Updates
2.3 Piramal Pharma
2.3.1 Piramal Pharma Details
2.3.2 Piramal Pharma Major Business
2.3.3 Piramal Pharma Morphine Sulfate Injection Product and Services
2.3.4 Piramal Pharma Morphine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Piramal Pharma Recent Developments/Updates
2.4 Fresenius Kabi
2.4.1 Fresenius Kabi Details
2.4.2 Fresenius Kabi Major Business
2.4.3 Fresenius Kabi Morphine Sulfate Injection Product and Services
2.4.4 Fresenius Kabi Morphine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Fresenius Kabi Recent Developments/Updates
2.5 Sterinova
2.5.1 Sterinova Details
2.5.2 Sterinova Major Business
2.5.3 Sterinova Morphine Sulfate Injection Product and Services
2.5.4 Sterinova Morphine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sterinova Recent Developments/Updates
2.6 Nephron Pharmaceuticals
2.6.1 Nephron Pharmaceuticals Details
2.6.2 Nephron Pharmaceuticals Major Business
2.6.3 Nephron Pharmaceuticals Morphine Sulfate Injection Product and Services
2.6.4 Nephron Pharmaceuticals Morphine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Nephron Pharmaceuticals Recent Developments/Updates
2.7 Qinghai Pharmaceutical
2.7.1 Qinghai Pharmaceutical Details
2.7.2 Qinghai Pharmaceutical Major Business
2.7.3 Qinghai Pharmaceutical Morphine Sulfate Injection Product and Services
2.7.4 Qinghai Pharmaceutical Morphine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Qinghai Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Morphine Sulfate Injection by Manufacturer
3.1 Global Morphine Sulfate Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Morphine Sulfate Injection Revenue by Manufacturer (2018-2023)
3.3 Global Morphine Sulfate Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Morphine Sulfate Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Morphine Sulfate Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Morphine Sulfate Injection Manufacturer Market Share in 2022
3.5 Morphine Sulfate Injection Market: Overall Company Footprint Analysis
3.5.1 Morphine Sulfate Injection Market: Region Footprint
3.5.2 Morphine Sulfate Injection Market: Company Product Type Footprint
3.5.3 Morphine Sulfate Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Morphine Sulfate Injection Market Size by Region
4.1.1 Global Morphine Sulfate Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Morphine Sulfate Injection Consumption Value by Region (2018-2029)
4.1.3 Global Morphine Sulfate Injection Average Price by Region (2018-2029)
4.2 North America Morphine Sulfate Injection Consumption Value (2018-2029)
4.3 Europe Morphine Sulfate Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Morphine Sulfate Injection Consumption Value (2018-2029)
4.5 South America Morphine Sulfate Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Morphine Sulfate Injection Consumption Value (2018-2029)
5 Market Segment by Drug Concentration
5.1 Global Morphine Sulfate Injection Sales Quantity by Drug Concentration (2018-2029)
5.2 Global Morphine Sulfate Injection Consumption Value by Drug Concentration (2018-2029)
5.3 Global Morphine Sulfate Injection Average Price by Drug Concentration (2018-2029)
6 Market Segment by Application
6.1 Global Morphine Sulfate Injection Sales Quantity by Application (2018-2029)
6.2 Global Morphine Sulfate Injection Consumption Value by Application (2018-2029)
6.3 Global Morphine Sulfate Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Morphine Sulfate Injection Sales Quantity by Drug Concentration (2018-2029)
7.2 North America Morphine Sulfate Injection Sales Quantity by Application (2018-2029)
7.3 North America Morphine Sulfate Injection Market Size by Country
7.3.1 North America Morphine Sulfate Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Morphine Sulfate Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Morphine Sulfate Injection Sales Quantity by Drug Concentration (2018-2029)
8.2 Europe Morphine Sulfate Injection Sales Quantity by Application (2018-2029)
8.3 Europe Morphine Sulfate Injection Market Size by Country
8.3.1 Europe Morphine Sulfate Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Morphine Sulfate Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Morphine Sulfate Injection Sales Quantity by Drug Concentration (2018-2029)
9.2 Asia-Pacific Morphine Sulfate Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Morphine Sulfate Injection Market Size by Region
9.3.1 Asia-Pacific Morphine Sulfate Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Morphine Sulfate Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Morphine Sulfate Injection Sales Quantity by Drug Concentration (2018-2029)
10.2 South America Morphine Sulfate Injection Sales Quantity by Application (2018-2029)
10.3 South America Morphine Sulfate Injection Market Size by Country
10.3.1 South America Morphine Sulfate Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Morphine Sulfate Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Morphine Sulfate Injection Sales Quantity by Drug Concentration (2018-2029)
11.2 Middle East & Africa Morphine Sulfate Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Morphine Sulfate Injection Market Size by Country
11.3.1 Middle East & Africa Morphine Sulfate Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Morphine Sulfate Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Morphine Sulfate Injection Market Drivers
12.2 Morphine Sulfate Injection Market Restraints
12.3 Morphine Sulfate Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Morphine Sulfate Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Morphine Sulfate Injection
13.3 Morphine Sulfate Injection Production Process
13.4 Morphine Sulfate Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Morphine Sulfate Injection Typical Distributors
14.3 Morphine Sulfate Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’